Bausch Health (MEX:BHCN) Other Financing: MXN-2,241 Mil (TTM As of Mar. 2026)


MEX:BHCN Bausch Health Companies Inc MEX:BHCN
48 GF Score
Price MXN85.44
GF Value MXN188.23
Valuation Possible Value Trap
! 3 Warning Signs
View Full Analysis

What is Bausch Health Other Financing?

Bausch Health MEX:BHCN 48 Other Financing is MXN-2,241 Mil as of Mar. 2026. GuruFocus rates MEX:BHCN with a GF Score™ of 48/100 and a GF Value™ of MXN188.23 (Possible Value Trap). The stock has 3 warning signs investors should review.

Bausch Health's Other Financing for the three months ended in Mar. 2026 was MXN-811 Mil.

Bausch Health's Other Financing for the trailing twelve months (TTM) ended in Mar. 2026 was MXN-2,241 Mil.

Bausch Health Other Financing Historical Data

* Premium members only.

The historical data trend for Bausch Health's Other Financing can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Bausch Health Other Financing Chart

Bausch Health Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Other Financing
Get a 7-Day Free Trial Premium Member Only Premium Member Only -3,548.92 -2,709.94 -1,799.27 -1,439.04 -1,890.60

Bausch Health Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Other Financing Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -572.83 -884.97 -256.82 -288.09 -811.47
MEX:BHCN
48GF Score
Bausch Health Companies Inc MEX:BHCN
Other Financing is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Bausch Health Other Financing Calculation

Other Financing represents other cash flow from financing activity that not otherwise classified, which includes:
Proceeds From Stock Option Exercised
Other Financing Charges

Other Financing for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was MXN-2,241 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Other Financing →
What does a Other Financing of MXN-2,241 Mil mean?
Bausch Health (MEX:BHCN) has a Other Financing of MXN-2,241 Mil as of Mar. 2026. Other Financing represents other cash flow from financing activity that not otherwise classified. View historical data for Bausch Health and its competitors.
Is Bausch Health's Other Financing too high?
Bausch Health's current Other Financing is MXN-2,241 Mil. Overall, Bausch Health has a GF Score™ of 48/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Bausch Health's Other Financing compare to ZTS?
Bausch Health's Other Financing of MXN-2,241 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Financing for a Drug Manufacturers company?
A good Other Financing depends on the Drug Manufacturers industry context. However, Other Financing should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Financing mean?
A high Other Financing can signal that a stock is expensive relative to its fundamentals. Other Financing represents other cash flow from financing activity that not otherwise classified. View historical data for Bausch Health and its competitors. Bausch Health's current Other Financing is MXN-2,241 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Bausch Health stock overvalued right now?
Based on GuruFocus' analysis, Bausch Health (MEX:BHCN) is currently considered Possible Value Trap. The stock's GF Value™ is MXN188.23, compared to a current price of MXN85.44 — trading 54.6% below its estimated fair value. The current Other Financing is MXN-2,241 Mil. Bausch Health's overall GF Score™ is 48/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Financing calculated?
Other Financing is calculated from a company's financial statements. For Bausch Health (MEX:BHCN), the current Other Financing is MXN-2,241 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Bausch Health (MEX:BHCN) Overvalued in 2026?

Based on GuruFocus' analysis, Bausch Health stock appears to be undervalued. The current stock price of MXN85.44 is trading 54.6% below its estimated GF Value™ of MXN188.23. GuruFocus considers Bausch Health to be Possible Value Trap.

Key valuation signals for MEX:BHCN:

  • Other Financing: MXN-2,241 Mil
  • GF Value™: MXN188.23 vs. price of MXN85.44 (54.6% below fair value)
  • GF Score™: 48/100 with 3 warning signs

No single metric tells the full story. See the MEX:BHCN stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Bausch Health Business Description

Address 2150 St Elzear Boulvard West, Laval, QC, CAN, H7L 4A8
Bausch Health Companies Inc is a world-wide specialty pharmaceutical, consumer health, and medical device company with a focus on branded products for the gastroenterology, hepatology, neurology and dermatology markets. The company reports revenue in five segments: Salix; International; Solta Medical; Diversified Products and Bausch + Lomb. It generates maximum of its revenue from the Bausch + Lomb segment.
48GF Score

Get the complete analysis for MEX:BHCN

Other Financing is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

MXN85.44
Price
MXN188.23
GF Value